Literature DB >> 10357569

Epidemiology of hypertriglyceridemia and cardiovascular disease.

M A Austin1.   

Abstract

Epidemiologic studies provide increasing evidence that hypertriglyceridemia is a risk factor for cardiovascular disease. A meta-analysis of 17 population-based studies of triglyceride levels and cardiovascular disease identified a 76% increase in cardiovascular disease risk in women and a 31% increase in men associated with a 1 mmol/L increase in triglyceride levels. Additional epidemiologic studies have shown that plasma triglyceride levels and low-density lipoprotein particle size predict subsequent coronary artery disease. Taken together, the existing epidemiologic data may help identify a group of patients who may benefit from interventions aimed at decreasing triglyceride levels associated with an increased risk of cardiovascular disease.

Entities:  

Mesh:

Year:  1999        PMID: 10357569     DOI: 10.1016/s0002-9149(99)00209-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

Review 1.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

2.  APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population.

Authors:  Carmen Sánchez-Moreno; Jose M Ordovás; Caren E Smith; Juan C Baraza; Yu-Chi Lee; Marta Garaulet
Journal:  J Nutr       Date:  2011-01-05       Impact factor: 4.798

3.  Lipoprotein(a) and SYNTAX Score Association with Severity of Coronary Artery Atherosclerosis in North India.

Authors:  Fauzia Ashfaq; P K Goel; Nagraja Moorthy; Rishi Sethi; Mohammed Idrees Khan; Mohammed Zafar Idris
Journal:  Sultan Qaboos Univ Med J       Date:  2012-11-20

4.  Effect of experimental hyperlipidaemia on the electrocardiographic effects of repeated doses of halofantrine in rats.

Authors:  Jigar P Patel; Dion R Brocks
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

5.  Hyperphagia modifies FA profiles of plasma phospholipids, plasma FFA, and adipose tissue TAG.

Authors:  Gudrun V Skuladottir; Pall I Olason; Logi Jonsson; Jon O Skarphedinsson; Vedis H Eriksdottir; Palmi Th Atlason; Leifur Franzson; Helgi B Schiöth
Journal:  Lipids       Date:  2003-11       Impact factor: 1.880

6.  An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients.

Authors:  Clive R Pullinger; Bradley E Aouizerat; Irina Movsesyan; Vincent Durlach; Eric J Sijbrands; Katsuyuki Nakajima; Annie Poon; Geesje M Dallinga-Thie; Hiroaki Hattori; Lauri L Green; Pui-Yan Kwok; Richard J Havel; Philip H Frost; Mary J Malloy; John P Kane
Journal:  J Lipid Res       Date:  2008-04-25       Impact factor: 5.922

7.  Separation of postprandial lipoproteins: improved purification of chylomicrons using an ApoB100 immunoaffinity method.

Authors:  Grace Marie Jones; Russell Caccavello; Sergiu P Palii; Clive R Pullinger; John P Kane; Kathleen Mulligan; Alejandro Gugliucci; Jean-Marc Schwarz
Journal:  J Lipid Res       Date:  2019-12-30       Impact factor: 5.922

8.  Cardiovascular risk factor investigation: a pediatric issue.

Authors:  Anabel N Rodrigues; Glaucia R Abreu; Rogério S Resende; Washington Ls Goncalves; Sonia Alves Gouvea
Journal:  Int J Gen Med       Date:  2013-03-05

9.  Lipoprotein (a) Levels in Relation to Severity of Coronary Artery Disease in North Indian Patients.

Authors:  Fauzia Ashfaq; Pravin Kumar Goel; Rishi Sethi; Mohd Idrees Khan; Wahid Ali; Mohd Zafar Idris
Journal:  Heart Views       Date:  2013-01

10.  Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis.

Authors:  Wei Liu; Yubin Cao; Li Dong; Ye Zhu; Yafei Wu; Zongkai Lv; Zipporah Iheozor-Ejiofor; Chunjie Li
Journal:  Cochrane Database Syst Rev       Date:  2019-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.